Navigation Links
Metastatic bone disease patients can walk in Lazarus' footsteps
Date:3/9/2009

SAN DIEGO, Calif. (March 9, 2009)Osteoplastya highly effective minimally invasive procedure to treat the painful effects of metastatic bone disease by injecting bone cement to support weakened bonesprovides immediate and substantial pain relief, often presenting individuals who are suffering terribly with the miraculous so-called "Lazarus effect," according to researchers at the Society of Interventional Radiology's 34th Annual Scientific Meeting. Interventional radiologists often couple osteoplasty with heat or cold treatments to kill tumor nerves, if needed.

"The immediate good clinical results observed in our patients should encourage more widespread application of this palliative interventional radiology treatment," said Giovanni C. Anselmetti, M.D., interventional radiologist at the Institute for Cancer Research and Treatment in Turin, Italy. "A patient's quality of life can be severely affected when they have metastatic bone disease. Normal daily activities can become difficult when the metastases become painful, and many patients report that their sleep patterns change, appetite diminishes and the need to take pain relief medications increases," he noted. "Osteoplasty is not a first-line treatment. It is a highly effective minimally invasive procedure that provides pain relief for patients not responding to conventional pain medication treatments," he said. "Metastatic bone disease patientswho have no other options, who are in pain, who have short life expectancies and who have dismal quality of lifeshould be referred to interventional radiologists for osteoplasty treatment. Interventional radiologists can improve the quality of life for patients who have very large metastases and who are going to die because of their primary cancers," added Anselmetti.

Metastatic bone disease is a painful condition that can develop in conjunction with cancers of the breast, bladder, kidney, lung or other organs. It occurs when cancer cells at an origin
'/>"/>

Contact: Maryann Verrillo
mverrillo@SIRweb.org
703-460-5572
Society of Interventional Radiology
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. $2.7 million awarded for metastatic colon cancer research
2. Standard chemo works better against metastatic BRCA1/2 breast cancer than against sporadic tumors
3. Metastatic movements in 3-D
4. Antioxidant overload may underlie a heritable human disease
5. Gender, coupled with diabetes, affects vascular disease development
6. Study links cat disease to flame retardants in furniture and to pet food
7. Humans fostering forest-destroying disease
8. Emerging (disease) markets
9. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
10. Clemson chemists discover new way antioxidants fight debilitating diseases
11. Finding that 1-in-a-billion that could lead to disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...erman . , The DFG has approved the establish...f 1 January 2010. This decision was made recently ...centres will initially be funded for four years wi... overhead funding for indirect costs will also be ...opics range from modern prostheses to political re...
(Date:11/30/2009)...are crucial for infection. Each binds a specific r...lates the host cell to take up the pathogen. Norma...nction, for example the regulation of cell growth ...en published in the current issue of the " Journal...f the sources for Listeria infections leading to...
(Date:11/30/2009)...in the December 2009 print issue of The FASEB Jou...ol over their fertility that women have had since ...w and where androgenic hormones work in the testis...lity. This opens a promising avenue for the develo...fers hope to those who cannot have children becaus...
Breaking Biology News(10 mins):DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9It takes 2 to infect 2Give an Hour 28TM 29s Volunteer Mental Health Professionals Provide Nearly 241 7 Million in Services to Iraq and Afghanistan Veterans Families and 56394 1Give an Hour 28TM 29s Volunteer Mental Health Professionals Provide Nearly 241 7 Million in Services to Iraq and Afghanistan Veterans Families and 56394 2Beike Biotech Adds International Executives to Strengthen Current Technologies and Develop Future Pipeline 13903 1Beike Biotech Adds International Executives to Strengthen Current Technologies and Develop Future Pipeline 13903 2Beike Biotech Adds International Executives to Strengthen Current Technologies and Develop Future Pipeline 13903 3Media registration for ECCO 15 ESMO 34 multidisciplinary cancer congress 56392 1Media registration for ECCO 15 ESMO 34 multidisciplinary cancer congress 56392 2Media registration for ECCO 15 ESMO 34 multidisciplinary cancer congress 56392 3
...proteins are the bad guys that help bacterial path...ing the body,s immune system. In essence, they kn...he cell,s alarm system. , Now, researchers at the ...of Medicine have identified a novel molecular targ...eral effectors of the bacteria Yersinia – the path...
...ge research has found that a new gene therapy can ... reduce long-term damage to the affected joints, a... Arthritis and Rheumatism. While the study was don...ed to develop osteoarthritis like humans, with the...likely to develop the disease, the authors said. I...
...tically engineered to lack a single enzyme in thei...mal cousins, and are quicker to figure out that th...hers at UT Southwestern Medical Center has found. ...tion of the journal Nature Neuroscience , reveal ...ght serve in humans as a target for treating disor...
Other Biology News:How plague-causing bacteria disarm host defense 2Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 2Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 3Experimental gene therapy 'abolishes' arthritis pain and lessens joint damage 4'Smart' mice teach scientists about learning process, brain disorders 2
(Date:12/1/2009)...1 PDL BioPharma, Inc. (P...nce for the fourth quarter ended December 31, 2009...9 million for the fourth quarter of 2008. Included...wo installment payments of $12.5 million from Alex... was a one-time $1.8 million payment from Genentec...
(Date:12/1/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Industrial Enzymes - A Global Market Re...Industrial-Enzymes---A-Global-Market-Report.html ...th few strong players and a host of small supplier...tion and commoditization characterize the industry...
(Date:12/1/2009)...Newswire/ -- Harvest Technologies Corp. ( www.harv...pany sponsored 60-patient clinical trial conducted...ia using the company,s BMAC System to treat patien... (CLI). Sri Ramachandra Medical Center is a Harvar...ed in Chennai, India and one of the largest privat...
(Date:12/1/2009)... Richard Gephardt Brings Together A-List from New ...r "Best and Brightest Forum on Medical Innovation...Newswire/ -- Several of New Jersey,s most prominen...e and technology gathered today at the Liberty Sci...nnovation in New Jersey, and throughout the United...
Breaking Biology Technology:PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5
...2 Edwards Lifesciences,Corporation (NYSE: EW ), ...at advanced cardiovascular disease, today announce...ueli School of Engineering at the,University of Ca...nces,Center for Advanced Cardiovascular Technology...veloping the next generation of cardiovascular,dev...
...., Sept. 12 ABR-Affinity,BioReagents, a leading g...,the research antibody marketplace through distrib...tech Corporation. Complementing existing distribu...rontier, ABR-Affinity BioReagents today finalized ... a manufacturer of antibodies,focusing on gene fun...
... Two new white papers detailing,sterility testing...om,Microtest ( http://www.microtestlabs.com ). The... device manufacturers and one which is specialized...neral concepts and,problems associated with steril...ogies. For medical device manufacturers, sterilit...
Other Biology Technology:Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology 2ABR-Affinity BioReagents Announces Agreements for U.S. Distribution of Research Antibodies 2Free White Papers Detail Sterility Testing Essentials for Medical Device, Pharmaceutical Manufacturers 2
...or high-yield protein expression ,The uniqu... clone of Sf9 cells. Pre-adapted for growth in Nov...lls are recommended for superior growth and protei...ection of appropriate vectors. For cotransfection ...
Mouse Anti-Human VRK2 Monoclonal Antibody, Unconjugated, Clone 3B10 from Abnova Corporation
Mouse Anti-Human SCGB3A2 Monoclonal Antibody, Unconjugated, Clone 1B2 from Abnova Corporation
BD 96-well format from BD Biosciences - Discovery Labware
Biology Products: